Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425459 · ClinicalTrials.gov registry record · NA
RESPONDER-HF Trial
A NA study of Heart Failure and Heart Failure, Diastolic, sponsored by Corvia Medical.
- Active
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 20
- Study locations
NCT05425459 is a NA study of Heart Failure and Heart Failure, Diastolic that is active but no longer recruiting, run by Corvia Medical. The registered enrollment target is 750 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (63% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT05425459, a NA study of Heart Failure and Heart Failure, Diastolic, is active but no longer recruiting, sponsored by Corvia Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multicenter, Prospective, Randomized, Sham Controlled, Double Blinded Clinical Trial, with; 1:1 randomization
Conditions Studied
Interventions
- DEVICE Corvia Atrial Shunt System / IASD System II
- OTHER Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)
Study Locations (20)
Florida
- Memorial Regional Hospital - Hollywood
- NCH Naples - Naples
- Cleveland Clinic Florida - Weston
Illinois
- Northwestern University - Chicago
- University of Chicago Medical Center - Chicago
- Endeavor Health-Northshore - Glenview
California
- Scripps Clinic - La Jolla
- MemorialCare Long Beach Medical Center - Long Beach
Georgia
- Northside Hospital Gwinnett Campus - Lawrenceville
- Wellstar Kennestone - Marietta
Massachusetts
- Lahey Hospital & Medical Center - Burlington
- UMass Memorial Hospital University Campus - Worcester
Arizona
- Arizona Cardiovascular Research Center - Phoenix
Delaware
- Christiana Care Health Services - Newark
Louisiana
- LSU Health Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2031-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05425459
The ClinicalTrials.gov registry entry for NCT05425459 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (63% lower). The listed sponsor is Corvia Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Corvia Atrial Shunt System / IASD System II is the first listed.
NCT05425459 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Illinois, California.
Frequently Asked Questions
What is clinical trial NCT05425459 about?
NCT05425459 is a clinical study titled "RESPONDER-HF Trial". Multicenter, Prospective, Randomized, Sham Controlled, Double Blinded Clinical Trial, with; 1:1 randomization
What is the current status of trial NCT05425459?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2022-11-17. Estimated completion is 2031-03.
What conditions does trial NCT05425459 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure, Diastolic.
What interventions are being tested in trial NCT05425459?
The interventions under investigation include: Corvia Atrial Shunt System / IASD System II (DEVICE), Intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE) (OTHER).
Who is sponsoring clinical trial NCT05425459?
This trial is sponsored by Corvia Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05425459 being conducted?
This trial has 20 study locations across Arizona, California, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.